3 completed, 3 recruiting, 1 active not recruiting. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 3, Active not recruiting 1 |
| Phase 1 | 3 | Completed 3 |
Follow Frantz Viral Therapeutics, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants Artesunate ointment, Placebo - Anal High-grade Squamous Intraepithelial Lesion, Anal HSIL | Phase 2 | Recruiting | Frantz Viral Therapeutics, LLC | 48 | 2024-01-12 | 2025-05-18 |
| Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) Artesunate ointment, Placebo ointment - Vulvar Diseases, HPV Infection | Phase 2 | Recruiting | Frantz Viral Therapeutics, LLC | 27 | 2023-12-06 | 2025-08-14 |
| Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL Artesunate, Placebo - Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition | Phase 2 | Active not recruiting | Frantz Viral Therapeutics, LLC | 17 | 2023-02-10 | 2025-05-18 |
| Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) Artesunate vaginal insert, Placebo vaginal insert - CIN 2/3, HPV Infection | Phase 2 | Recruiting | Frantz Viral Therapeutics, LLC | 78 | 2020-09-09 | 2025-10-02 |
| Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) artesunate ointment 40% - Vulvar Dysplasia, HPV-Related Vulvar Intraepithelial Neoplasia | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 15 | 2019-04-17 | 2024-12-04 |
| Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3) Artesunate Suppositories - HPV-Related Anal Intraepithelial Neoplasia, AIN2/3 | Phase 1 | Completed | Johns Hopkins University | 18 | 2017-04-20 | 2021-11-03 |
| Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3) Artesunate Suppositories - Cervical Intraepithelial Neoplasia Grade 2/3, High-risk HPV (Any Strain) | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 30 | 2015-02-01 | 2021-04-28 |
Papillomavirus Infections (3) · Uterine Cervical Dysplasia (2) · Vulvar Diseases (2) · Precancerous Conditions (1)
artemisinin (5) · artesunic acid (4) · artenimol (3) · Artesunate (1)
United States (7)
Cornelia L Trimble, MD (2) · Joel Palefsky, MD (1) · Sandy H Fang, MD (1)